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Abstract Apoptotic cells show morphological modifications
which occur as the result of complex molecular mechanisms
involving several proteins including ‘tissue’ transglutaminase
(tTG). Although tTG was originally thought to be responsible for
the protein crosslinks which prevent the leakage of intracellular
components, thereby reducing inflammation and autoimmunity,
recent evidence indicates that tTG is a multifunctional enzyme
involved in the complex upstream regulation of the apoptotic
machinery: (i) it functions as a GTP-binding protein to transduce
signals; (ii) it binds/crosslinks only specific cytosolic and nuclear
substrates, suggesting highly specific actions, e.g. on intermedi-
ate filaments and in cell cycle control ; (iii) it is finely tuned by
Ca2+, GTP, S-nitrosylation, polyamines. In light of these recent
discoveries, the role of tTG in the regulation of the crucial
balance between survival and death is clearly complex.
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1. Introduction
Cells undergoing apoptosis are characterised by typical ul-
trastructural modi¢cations which involve complex molecular
mechanisms regulated at both the transcriptional and the
post-transcriptional levels [1,2]. While most proteins involved
in the apoptotic pathway have been shown to follow common
pathways, see for example Fig. 1, the role of ‘tissue’ trans-
glutaminase (tTG or type 2 TGase; EC 2.3.2.13) has not been
fully de¢ned. In this review, we will discuss some recent devel-
opments on the role of tTG.
tTG belongs to the transglutaminase family which includes
intracellular and extracellular enzymes catalysing Ca2-de-
pendent reactions resulting in the formation of the O(Q-gluta-
myl)lysine crosslinks and/or to the covalent incorporation of
di- and polyamines and histamine [3]. tTG, like all TGases [4],
is formed by an N-terminal domain, a catalytic domain and
two L-barrels (Fig. 2). The catalytic pocket is identical to that
of the cysteine proteases (Fig. 3), with the exception of the
absence of H2O. This water-depleted structure prevents the
complete reaction from occurring and therefore the structure
must revert to its original conformation using a di¡erent ami-
no group (lysine or polyamines) with a long aliphatic chain.
The product of the reaction is a pseudo-isodipeptide bond.
Diamines and polyamines may also participate in crosslinking
reactions through the formation of N,N-bis(Q-glutamyl)poly-
amine bonds [5]. The establishment of these covalent cross-
links leads to the post-translational modi¢cation and, in many
instances, the oligomerisation of substrate proteins. The re-
sulting protein polymers have peculiar features of resistance
to breakage and chemical attack and can release polypeptides
only through the proteolytic degradation of protein chains. In
fact, endoproteases capable of hydrolysing the crosslinks
formed by TGases have been described only in leech saliva [6].
Although the tTG gene is constitutively expressed in some
cell types localised in select mammalian tissues, the onset of
apoptosis in vivo is often characterised by the induction of the
tTG gene. The presence and activity of the enzyme has been
shown to increase in apoptotic cells in numerous in vivo and
in vitro cell death models [7^9]. The activation of the tTG
protein in the dying cells results in the assembly of a highly
crosslinked intracellular protein net stabilised by both spermi-
dine-derived and O(Q-glutamyl)lysine crosslinks. Previous stud-
ies have suggested that the activation of tTG leads to the
assembly of intracellular crosslinked protein polymers which
irreversibly modi¢es cell organisation contributing to the wide
ultrastructural changes occurring in cells undergoing apopto-
sis [7,8]. This extensive tTG-dependent protein polymerisation
stabilises apoptotic cells before their clearance by phagocyto-
sis, thus contributing to the prevention of in£ammation in the
surrounding tissues [10]. Thus, tTG can be said to play a role
‘downstream’ in the e¡ector/degradation phases of apoptosis.
This ‘downstream role’ concept originated from the peculiar
form of cell death occurring in the skin where keratinocytes
di¡erentiate, before dying, to producing all ingredients neces-
sary for tissue function such as TGases and their substrates.
The dead keratinocytes play a crucial role in the structure of
the organism, as they confer resistance and elasticity, and
serve as a barrier against water. Morphological, biochemical
and molecular studies [11] have shown that this process occurs
in stages and is characterised by the sequential expression of
several proteins. The keratins K5 and K14 are the main prod-
ucts of the proliferant basal cells and are assembled as 10-nm
long intermediate ¢laments which extend from the desmo-
somes toward the nuclear lamina and, along with microtu-
bules and the micro¢laments, form the cytoskeleton of the
epithelial cells. Normally, keratinocytes lose their mitotic ac-
tivity when they migrate to the spinous layer where they begin
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to synthesise several proteins of intermediate ¢laments (des-
moplachine I and II and desmoglein I) including speci¢c ker-
atins of the epidermal di¡erentiation, K1 and K10 instead of
K5 and K14, which are then assembled in bunches. In the
more advanced stages of di¡erentiation, the cells acquire ker-
atohyalin granules, which are composed mainly of a ¢laggrin
precursor. A series of proteins (loricrin, trichohyalin and
SPRs) are simultaneously deposited and polymerised by the
TGases from underneath the plasma membrane in order to
build a collective structure called the corni¢ed envelope (CE)
[11]. From a biochemical point of view, the CE is the most
insoluble component of the corni¢ed epithelium and is a com-
plex structure in terms of protein and lipid composition.
Many proteins are CE precursors and function as transgluta-
minase (TGase 1 and TGase 3) substrates. Although the in-
solubility of the CE is accompanied by crosslinks O(Q-glutam-
yl)-lysine, catalysed by Ca2-dependent TGases [11] and by
disulfur bridges, the sequence of events that leads to the for-
mation of the CE is not clear. Nonetheless, the action of
TGases is highly speci¢c [12,13]. Due to the presence of cross-
links, they are resistant to proteolysis. Mutations in TGase 1
result in the loss of activity or the loss of proteolytic activa-
tion, and thus cause the skin disorder lamellar ichthyosis,
which is characterised by polygonal scales and follicular ker-
atosis [14].
Although studies clearly indicate that TGases play a ‘down-
stream’ role in the process of skin keratinisation, the role and
position of tTG in the apoptotic pathway is not so evident.
Can these observations made in a skin model be applied to a
di¡erent type of TGase in a more broad biochemical process?
Several recent ¢ndings seem to suggest a more complex or-
ganisation of events.
2. ‘Tissue’ transglutaminase and its substrates in apoptosis
During apoptosis, the tTG gene is transcribed, the enzyme
is synthesised and prompted to crosslink. The de novo tran-
scription of the tTG gene is induced by several factors (reti-
noic acid, prostaglandin E2, interleukin 6, tumour growth
factor L) which also modulate apoptosis. This regulation by
multiple factors might be typical of the e¡ector elements of
the cell death program. In fact, the sequence analysis of frag-
ments of the cloned genomic DNA has revealed the presence
of several binding sites for transcriptional factors known to
modulate apoptosis, thus indicating that the transcription of a
putative apoptotic ‘e¡ector’ gene can be controlled by a multi-
functional promoter [15^17]. The retinoid receptors involved
in the regulation of tTG and apoptosis have been recently
identi¢ed. The induction of apoptosis in both human neuro-
blastoma cells and in lymphocytes is under the speci¢c control
of RARK and RARQ [18,19].
We must assume that tTG is not active as a crosslinking
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Fig. 1. Simpli¢ed scheme of the cascade of events in apoptosis.
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enzyme in viable cells, and we assume that the ¢ne modula-
tion of the tTG protein by GTP, Ca2 [5] and nitric oxide by
S-nitrosylation [20], and possibly other molecules, such as free
putrescine and other polyamines [21], may explain how cells
are able to survive in the presence of high tTG protein levels
in their cytoplasm. Consistent with this hypothesis it is evident
that tTG acts as the GKh subunit, associated with the 50-kDa
L subunit (GLh), of the GTP-binding protein (Gh) in a ter-
nary complex associated with the rat liver K1-adrenergic re-
ceptor [22]. Thus, the tTG/GKh (this abbreviation indicates
the double function of the protein) is a multifunctional pro-
tein, which by binding GTP in a GKhGTP complex, can
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Fig. 2. Computerised homology model of ‘tissue’ transglutaminase based on the sequence identity with clotting factor XIII that has been re-
solved in its structure [4]. The model shows four domains depicted with di¡erent colours: N-terminal L-barrel sandwich domain (white), cata-
lytic domain (red), L-barrel 1 (green), L-barrel 2 (purple). The N-terminal activation peptide of fXIII is absent in tTG. In TGase 1, mutations
found in lamellar ichthyosis show the importance of the interface between the N-terminal domain and the central catalytic domain [14].
Fig. 3. Structural model of the active site of tTG in the catalytic domain shown above. The catalytic triade (Cys-277, His-335, Asp-358) is iden-
tical to other cysteine proteases, indicating a similarity in the mechanism of action. The colours of the four domains are as described above.
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modulate receptor-stimulated phospholipase-C activation.
The tTG/GKh represents a novel class of GTP-binding pro-
teins that participate in the receptor-mediated signalling path-
way. The GTP binding activity of tTG/GKh actively prevents
the activation of the crosslinking activity of tTG. In fact, the
Ca2-dependent crosslinking activity of tTG is ¢nely regulated
by GTP binding levels which in turn regulate secondary mes-
sengers, such as the production of inositol-1,4,5-triphosphate
and sn-1,2-diacylglycerol (DAG) from phosphatidylinositol-
4,5-biphosphate [22].
In light of these ¢ndings, we can hypothesise that tTG ex-
pression in its G-protein con¢guration in viable cells is related
to the prevention of cell death. In fact, the DAG-mediated
activation of protein kinase C, is one of the apoptosis-inhibit-
ing pathways [23]. Nevertheless, cells constitutively expressing
tTG are localised in tissue areas exposed to environmental
and functional stress; and in order to avoid harmful conse-
quences, they might keep the apoptotic machinery in place,
ready to act whenever their integrity is a¡ected. It has been
shown that some of the biochemical features of apoptosis can
be reproduced in anucleated cells, not requiring protein syn-
thesis. Thus, we may speculate that in the course of evolution,
the tTG gene acquired a cell-type-speci¢c regulation, which
allows for the accumulation of the enzyme under a crosslink-
ing inactive con¢guration in cells particularly exposed to en-
vironmental stress. These ¢ndings raise the important ques-
tion of the regulation of the e¡ector genes during the priming/
execution phase of apoptosis.
tTG has, therefore, at least two di¡erent functions that lead
to opposite e¡ects: life and death. The concept of multifunc-
tional proteins controlling apoptosis vs. survival is neither
unique nor novel, and highlights the complexity of these reg-
ulations. Indeed, proteins of the Ced-9/Bcl-2 family show op-
posite e¡ects, and in some cases the same gene generates pro-
teins with di¡erent e¡ects by alternative mRNA splicing or
post-translational modi¢cations, e.g. Ced-9 or Bcl-XL and
Bcl-XS [24,25]. Caspases, too, include proteins with or without
death domains, able to balance each other, e.g. caspase 8
(FLICE) [26] and FLIP [27]. The case of cytochrome c is
unique: the same protein is involved in mitochondrial electron
transport (necessary for survival) or in the activation of casp-
ase 9 (in conjunction with apaf 1 and ATP) [28], depending on
the intracellular localisation (Fig. 1).
The biochemical characterisation of the crosslinked protein
polymers formed by tTG in dying cells has revealed the pres-
ence of several intracellular proteins (actin, annexin, vinculin,
¢bronectin and other unknown proteins) [29,30]. Recently, the
retinoblastoma protein (pRB) and troponin have also been
shown to undergo tTG-dependent polymerisation in apoptosis
[31,32]. In addition, tTG binds L-tubulin, glutathione trans-
ferase P1-1 and histone H2B (Piredda, Melino and Piacentini,
unpublished results). Most of these proteins are cleaved by
caspases and calpains during the cell death execution phase,
thus indicating that tTG and thiol proteases share several
target proteins. The presence of a cysteine active site is essen-
tial for the catalytic activity of tTG (Fig. 3), calpains and
caspases [33,34]. This ¢nding supports the biochemical simi-
larities existing between tTG and papain, a thiol protease
from which tTG is likely derived [35]. Considering that pa-
pain, like caspases, cleaves proteins at the Asp residues, these
observations suggest a papain-like ancestral thiol protease as
the original cell ‘executioner’. In the course of evolution, this
gene might have evolved into the di¡erent classes of execu-
tioners (caspases, calpains and tTG) able to mediate the
highly regulated form(s) of death present in multicellular or-
ganisms.
3. Is tTG an essential e¡ector element of apoptosis?
A de¢nitive role for tTG in apoptosis has not yet been
¢rmly established, although tTG expression does not seem
to be a late epiphenomenon. A crucial answer to this will
come from the experiment with the knock-out mouse which
is being carried out in our laboratory using constructs disrupt-
ing exon 4 or exon 5, forming the active site of tTG. It will
soon be clear whether tTG is essential in the central pathway
of apoptosis, and thus in embryonic development, or whether
it modulates apoptosis in an ancillary mode in a tissue- and
inducer-speci¢c fashion. Interesting clues supporting an im-
portant role for tTG in apoptosis derive from transfection
studies carried out in various mammalian cells. Human neuro-
blastoma SK-N-BE(2) [36], BALB-C 3T3 [37] and L929 ¢bro-
blasts [10] transfected with a full length tTG cDNA show a
large reduction in their proliferative capacity paralleled by an
increase in both spontaneous and induced apoptosis. Trans-
fection of neuroblastoma cells with a segment of the human
tTG complementary DNA in antisense orientation results in a
pronounced decrease of both spontaneous as well as induced
apoptosis [36]. Consistent with our data, it has recently been
reported that apoptosis induced by expression of polyglut-
amine stretches in COS-7 cells, mimicking the expansion of
CAG (glutamine) repeats, which is at the basis of the patho-
genesis of various neurodegenerative diseases, is suppressed by
tTG inhibitors [38]. These ¢ndings indicate an important bio-
chemical event for the induction of the structural changes
featured in cells dying by apoptosis in the tTG-catalysed irre-
versible crosslinking of intracellular protein. As discussed in
the previous paragraph, recent evidence indicates that in the
early stages of the death pathway, a regulated tTG-mediated
post-translational modi¢cation of speci¢c protein substrates
might play a role in the commitment to apoptosis. We have
recently shown that the polymerisation of pRB, which pre-
cedes apoptosis in U937 cells, is mediated by its post-transla-
tional modi¢cation catalysed by tTG [31], thus suggesting that
the activation of this crosslinking enzyme might determine an
irreversible commitment to death. While pRB plays a key role
in cell cycle control, the absence of functional pRB may result
in apoptosis rather than in uncontrolled cell proliferation.
Overexpression of functional pRB may induce apoptosis or
rescue cells from death, depending on the system; homozyg-
ous pRB-null mice die during gestation showing massive in-
duction of apoptosis during liver erythropoiesis and neuronal
development [39]. The functional implications of the tTG-de-
pendent polymerisation of pRB occurring during the early
phases of apoptosis are not clear. In keeping with the possi-
bility that pRB polymerisation might lead to its functional
inactivation, we showed that the tTG-dependent polymerisa-
tion of pRB is paralleled by the rapid disappearance of E2F-1,
which occurs when the transcription factor is not protected by
pRB binding from entering the Ub/proteasome pathway [31].
In keeping with its close relation to cell death, tTG has
already been shown to be involved in several pathologies:
from AIDS, to autoimmunity, to tumours, to neurodegener-
ative diseases [10,35,38,40,41].
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In conclusion, the idea that cell death by apoptosis was a
genetically regulated event has been con¢rmed by the identi-
¢cation of several genes participating in the process. However,
despite the exponential increase in the number of studies on
gene-dependent cell death, a single ‘killer’ gene has yet to be
identi¢ed in mammalian cells. A number of distinct enzymes
(i.e. caspase, calpains and tTG) might work together to
achieve the fast and immunologically silent removal of apop-
totic bodies. Under controlled physiological conditions, it is
very likely that di¡erent e¡ector elements have complementa-
ry integrated functions in di¡erent cell compartments.
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